CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 49.467
AS - Asia 26.173
EU - Europa 23.660
SA - Sud America 4.447
Continente sconosciuto - Info sul continente non disponibili 584
AF - Africa 475
OC - Oceania 32
Totale 104.838
Nazione #
US - Stati Uniti d'America 48.643
GB - Regno Unito 9.054
CN - Cina 7.712
SG - Singapore 7.171
HK - Hong Kong 3.857
IT - Italia 3.820
BR - Brasile 3.434
VN - Vietnam 2.683
DE - Germania 2.319
SE - Svezia 1.874
UA - Ucraina 1.839
FI - Finlandia 1.414
KR - Corea 1.034
BD - Bangladesh 956
RU - Federazione Russa 955
TR - Turchia 927
FR - Francia 889
BG - Bulgaria 666
IN - India 445
AR - Argentina 381
CA - Canada 370
ID - Indonesia 264
MX - Messico 198
IQ - Iraq 183
EC - Ecuador 180
NL - Olanda 138
ZA - Sudafrica 131
CO - Colombia 129
PK - Pakistan 111
ES - Italia 107
JP - Giappone 105
VE - Venezuela 94
AE - Emirati Arabi Uniti 93
PL - Polonia 92
IE - Irlanda 86
MA - Marocco 83
CL - Cile 81
PH - Filippine 72
MY - Malesia 66
SA - Arabia Saudita 61
JM - Giamaica 55
LT - Lituania 54
EG - Egitto 53
PY - Paraguay 53
KE - Kenya 51
UZ - Uzbekistan 51
IR - Iran 46
CR - Costa Rica 42
BE - Belgio 40
TN - Tunisia 39
PE - Perù 38
NP - Nepal 35
JO - Giordania 33
PT - Portogallo 33
UY - Uruguay 33
KZ - Kazakistan 30
CH - Svizzera 29
RO - Romania 29
TH - Thailandia 29
AZ - Azerbaigian 27
DZ - Algeria 26
AU - Australia 25
DO - Repubblica Dominicana 25
DK - Danimarca 24
EU - Europa 24
HN - Honduras 23
AL - Albania 22
AT - Austria 21
IL - Israele 20
BO - Bolivia 19
CZ - Repubblica Ceca 18
NI - Nicaragua 18
GR - Grecia 17
RS - Serbia 17
TT - Trinidad e Tobago 17
OM - Oman 16
BH - Bahrain 15
BY - Bielorussia 15
ET - Etiopia 15
GT - Guatemala 15
TW - Taiwan 15
KG - Kirghizistan 14
LB - Libano 13
PA - Panama 13
PR - Porto Rico 13
QA - Qatar 13
GE - Georgia 12
PS - Palestinian Territory 12
SI - Slovenia 12
SC - Seychelles 11
BA - Bosnia-Erzegovina 10
HR - Croazia 10
HU - Ungheria 10
NG - Nigeria 9
SK - Slovacchia (Repubblica Slovacca) 9
SN - Senegal 9
AM - Armenia 8
BB - Barbados 8
CY - Cipro 8
LV - Lettonia 8
Totale 104.126
Città #
Southend 7.074
Singapore 4.352
Santa Clara 4.056
Jacksonville 4.047
Hong Kong 3.800
Ashburn 3.767
Fairfield 3.613
Dearborn 2.598
Hefei 2.590
Woodbridge 2.284
Chandler 2.083
Houston 1.772
San Jose 1.767
Council Bluffs 1.538
Beijing 1.494
Wilmington 1.488
London 1.415
Seattle 1.248
Ann Arbor 1.236
Cambridge 1.151
Nyköping 1.120
Seoul 985
Ho Chi Minh City 907
The Dalles 873
Princeton 761
Los Angeles 760
Helsinki 758
Sofia 656
Eugene 640
Hanoi 638
Modena 608
Dallas 571
Lauterbourg 553
New York 513
Milan 508
Chicago 447
Buffalo 446
Columbus 435
Izmir 428
Bremen 423
San Diego 376
São Paulo 297
Shanghai 283
Moscow 243
Rome 191
Des Moines 187
Salt Lake City 155
Guangzhou 125
Haiphong 120
Orem 120
Norwalk 107
Da Nang 106
Miano 102
Atlanta 100
Rio de Janeiro 99
San Francisco 92
Frankfurt am Main 91
Jakarta 89
Kunming 87
Dublin 81
Nanjing 78
Tokyo 77
Tampa 76
Brooklyn 72
Toronto 71
Denver 68
Phoenix 68
Baghdad 67
Belo Horizonte 67
Bologna 65
Curitiba 64
Elk Grove Village 63
Brasília 62
Quito 61
Chennai 59
Montreal 58
Mexico City 56
Boardman 55
Charlotte 55
Amsterdam 53
Guayaquil 53
Munich 53
San Mateo 52
Biên Hòa 51
Johannesburg 51
Dhaka 50
Hải Dương 50
Tashkent 49
Naples 46
Campinas 45
Falls Church 44
Verona 44
Dubai 43
Manchester 43
Philadelphia 43
Warsaw 43
Jinan 42
Thái Bình 42
Falkenstein 41
Nairobi 41
Totale 71.675
Nome #
Diurnal variation of semen quality in human males. 682
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. 599
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 543
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 428
Intensity of menstrual pain and estimated angle of uterine flexion 416
Pulsatile luteinizing hormone release in postmenopausal women: effect of chronic bromocriptine administration. 389
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 381
Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 380
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function 365
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 359
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 353
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 349
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 347
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 340
Intermenstrual pelvic pain, quality of life and mood 338
Adenomyosis of the Extrapelvic Portion of the Round Ligament 337
Association between urinary incontinence and climacteric symptoms in postmenopausal women 333
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 328
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 322
Pharmacokinetic evaluation of desogestrel as a female contraceptive 321
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 320
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 316
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 314
Treatment of menopausal symptoms: concomitant modification of cortisol 312
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 308
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 307
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 306
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 305
Folate administration decreases oxidative status and blood pressure in postmenopausal women 303
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 303
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 299
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 298
Metabolic impact of combined hormonal contraceptives containing estradiol 298
Season of birth influences the timing of menopause 297
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 296
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 294
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 289
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 287
Recommendations for contraception in women with diabetes. AMD-SIC position paper 286
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 286
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 281
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 280
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 280
Melatonin in relation to physiology in adult humans 274
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 274
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 271
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 268
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 267
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 264
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 264
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 262
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 260
Medical and patient attitude towards vaginal atrophy: the AGATA study 259
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 258
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 256
Amplification of pulsatile LH secretion by exogenous melatonin in women. 256
A role for melatonin in PCOS? 255
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 255
Prevalence of menstrual pain in young women: What is dysmenorrhea? 254
Conseguenze dell'Isterectomia associata o no ad ovariectomia nella donna 254
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 254
Prolonged melatonin administration decreases nocturnal blood pressure in women 253
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 253
Anello Contraccettivo: i vantaggi della somministrazione vaginale 247
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 246
Contraccettivi con soli progestinici in perimenopausa.Effetti sul dispendio energetico e composizione corporea 246
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 246
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 246
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 245
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement. 245
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 243
Pharmacological, metabolic and clinical aspects of new oral contraceptive associations containing natural estrogens [Aspetti farmacologici, metabolici e clinici delle nuove associazioni contraccettive a base di estrogeni naturali] 242
Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome. 242
Drospirenone: dati di sicurezza a lungo termine 241
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 240
Melatonin enhances cortisol levels in aged but not young women. 240
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 237
Role of melatonin in circadian rhythm at menopause 234
Seasonal trend of acute pelvic inflammatory disease 234
Amplification of pulsatile LH secretion by exogenous melatonin in women 234
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women. 233
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 233
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 232
Hormone replacement therapy and glucose metabolism 232
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 232
European society of contraception statement on contraception in obese women 231
Influence of melatonin and photoperiod on animal and human reproduction 230
Ovary Cystadenofibroma Associated with Didelphys Uterus in a Teenager: Conservative Laparoscopic Management 230
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women. 230
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 230
A comparison of the central effects of different progestins used in hormone replacement therapy 228
Blood pressure and cardiovascular risk factors in women treated for climacteric symptoms with acupuncture, phytoestrogens, or hormones 228
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 227
Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. 226
Correlazione tra i livelli di omocisteina e densità minerale ossea in donne in postmenopausa. Uno studio longitudinale 225
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 225
Fattori implicati nel determinismo del sesso del nascituro 224
Effetti dell’ HRT e SERM sulla pressione arteriosa 224
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 223
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 221
Totale 28.658
Categoria #
all - tutte 398.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 398.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.560 0 0 483 459 142 334 250 390 941 573 704 1.284
2022/20236.690 972 573 365 449 1.184 1.018 125 616 891 60 225 212
2023/20244.666 201 264 198 332 1.266 515 622 569 74 59 117 449
2024/202515.613 486 186 115 1.142 3.078 2.003 936 720 2.249 1.091 1.169 2.438
2025/202629.749 1.457 1.520 3.988 4.026 2.537 1.818 3.289 1.888 2.599 3.017 2.052 1.558
2026/20276.900 2.130 3.121 1.649 0 0 0 0 0 0 0 0 0
Totale 104.838